UCN-01 and Irinotecan in Treating Patients With Metastatic or Unresectable Solid Tumors - Related Studies

UCN-01 and Irinotecan in Treating Patients With Metastatic or Unresectable Solid Tumors

This study is currently recruiting participants.

Study NCT00031681. Last updated on August 2, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Cancer

2	Interventions listed in this trial
		7-hydroxystaurosporine
		irinotecan hydrochloride
		laboratory biomarker analysis

3	Additional drug interventions recognized in this trial
		Camptothecin
		Irinotecan
		Staurosporine

4	More general drug interventions related to this trial
		Antineoplastic Agents
		Antineoplastic Agents, Phytogenic
		Enzyme Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Protein Kinase Inhibitors
		Therapeutic Uses

5	Sponsors listed in this trial
		Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
		National Cancer Institute (NCI)